Collaboration will allow Dr Reddy’s to identify and use some of the Biotechnology Industry Research Assistance Council’s clinical trial centres
This will be a multi-centre and randomised controlled study, which will include safety and immunogenicity study, Dr Reddy’s said in a statement.
The supplies of the medication to the Russian regions are expected soon, the Health Ministry told reporters, reports Tass news agency.
It appears that Professor Alexander Chuchalin wanted to block the registration of the vaccine on "safety" grounds, before quitting the ethics council, said the report on Thursday
12Page 2 of 2